Chemical methods to induce Beta-cell proliferation

Amedeo Vetere1, Bridget K Wagner

  • 1Chemical Biology Program, Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, MA 02142, USA.

Insights

Small molecules can induce pancreatic beta-cell regeneration by promoting proliferation, offering new diabetes treatments. This approach challenges the traditional view of quiescent beta cells and targets key cell-cycle proteins.

Area of Science:

  • Endocrinology
  • Cell Biology
  • Regenerative Medicine

Background:

  • Pancreatic beta cells are crucial for diabetes treatment, but their regenerative capacity is poorly understood.
  • Traditionally viewed as quiescent, recent findings suggest beta cells can increase mass under metabolic stress.
  • Understanding beta-cell regeneration mechanisms is key to developing novel diabetes therapies.

Purpose of the Study:

  • To review current trends in small-molecule approaches for inducing beta-cell regeneration.
  • To highlight the potential of targeting cell-cycle and signaling proteins for beta-cell proliferation.
  • To explore advances in cell culture enabling phenotypic screening for beta-cell regeneration.

Main Methods:

  • Review of current literature on small-molecule approaches for beta-cell regeneration.
  • Discussion of cell-cycle and signaling proteins as targets for drug discovery.
  • Overview of phenotypic screening methods for identifying compounds that induce beta-cell proliferation.

Main Results:

  • Small molecules show promise in inducing beta-cell proliferation and regeneration.
  • Targeting specific cell-cycle and signaling pathways is a viable strategy.
  • Advances in cell culture facilitate the screening of potential therapeutic agents.

Conclusions:

  • Small-molecule-driven beta-cell proliferation represents a promising avenue for diabetes treatment.
  • Further research into molecular mechanisms can lead to novel regenerative therapies.
  • Phenotypic screening offers a powerful tool for identifying regenerative compounds.

Related Concept Videos

Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.